Can-Fite BioPharma Ltd. EBITDA per Share 2011-2026 | CANF

EBITDA per Share Jährlich Can-Fite BioPharma Ltd.

2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	-0.01	-0.02	-0.04	-0.14	-0.14	0.154	0.251	0.221	1.4	-19.3	-17.4	-

Alle Zahlen in USD-Währung

Indikatorenreichweite aus Jahresberichten

Höchstwert	Mindestwert	Durchschnitt
1.4	-19.3	-3.18

EBITDA per Share anderer Aktien in der Pharmaeinzelhändler

Name	EBITDA per Share	Preis	% 24h	Marktkapitalisierung	Land
Acorda Therapeutics ACOR	-188	-	-24.86 %	$ 820 K	USA
Acasti Pharma ACST	-1.38	-	4.01 %	$ 150 M	Canada
MorphoSys AG MOR	-15.2	-	2.43 %	$ 254 M	Germany
ARCA biopharma ABIO	-5.25	-	1052.0 %	$ 415 M	USA
Albireo Pharma ALBO	-6.41	-	-0.23 %	$ 916 M	USA
Adagene ADAG	-0.63	$ 2.91	5.05 %	$ 164 M	China
ANI Pharmaceuticals ANIP	3.54	$ 82.0	3.13 %	$ 1.58 B	USA
Aytu BioScience AYTU	-0.39	$ 2.58	-1.53 %	$ 16.2 M	USA
Beam Therapeutics BEAM	-4.78	$ 29.29	0.93 %	$ 2.41 B	USA
Biogen BIIB	4.62	$ 176.18	0.77 %	$ 25.7 B	USA
Alexion Pharmaceuticals, Inc. ALXN	6.75	-	-	$ 40.3 B	USA
Aeglea BioTherapeutics AGLE	-6.7	-	-	$ 1.01 B	USA
Biophytis SA BPTS	-0.23	-	-13.47 %	$ 169 M	France
BioNTech SE BNTX	62.6	$ 116.77	0.53 %	$ 27.2 B	Germany
Midatech Pharma plc MTP	-0.09	-	-18.52 %	$ 27.3 M	Britain
EyeGate Pharmaceuticals, Inc. EYEG	2.22	-	-1.52 %	$ 24.7 M	USA
Alterity Therapeutics Limited ATHE	-1.68	$ 3.26	-3.55 %	$ 7.84 B	Australia
Akero Therapeutics AKRO	-4.25	-	-	$ 3.67 B	USA
Catalyst Biosciences CBIO	-1	$ 10.15	-5.45 %	$ 668 M	USA
Allena Pharmaceuticals ALNA	-0.696	-	3.16 %	$ 1.9 M	USA
AVROBIO AVRO	0.24	-	1083.1 %	$ 745 M	USA
Cerus Corporation CERS	-0.07	$ 2.32	-1.69 %	$ 428 M	USA
Aptose Biosciences APTO	0.05	-	-45.71 %	$ 1.2 M	Canada
Coherus BioSciences CHRS	-2.12	$ 2.33	5.19 %	$ 219 M	USA
Aravive ARAV	-1.92	-	-13.39 %	$ 1.45 M	USA
Brickell Biotech BBI	-1.17	-	-5.38 %	$ 6.06 M	USA
Applied Molecular Transport AMTI	-3.2	-	-	$ 10.1 M	USA
Институт стволовых клеток человека ISKJ	-2.69	-	-	-	Russia
Ascendis Pharma A/S ASND	-8.25	$ 223.95	0.67 %	$ 5 B	Danmark
Cellectis S.A. CLLS	-2.92	$ 3.99	-1.72 %	$ 116 M	France
Athira Pharma ATHA	-2.6	-	-	$ 269 M	USA
Atreca BCEL	0.14	-	-11.76 %	$ 5.79 M	USA
Burford Capital Limited BUR	1.11	$ 9.66	1.9 %	$ 1.52 B	Britain
Arrowhead Pharmaceuticals ARWR	0.9	$ 69.12	5.4 %	$ 9.25 B	USA
Catalyst Pharmaceuticals CPRX	1.65	$ 24.58	1.57 %	$ 2.91 B	USA
Cardiff Oncology CRDF	-1.01	$ 1.62	-0.31 %	$ 77.2 M	USA
Aeterna Zentaris AEZS	-0.08	-	5.93 %	$ 314 M	Canada
AgeX Therapeutics AGE	-9.04 K	-	-10.17 %	$ 12.2 K	USA
Akouos AKUS	-2.45	-	0.23 %	$ 488 M	USA
Bellicum Pharmaceuticals BLCM	-0.87	-	-9.72 %	$ 5.89 M	USA
Adaptimmune Therapeutics plc ADAP	-0.11	-	-15.15 %	$ 60.3 M	Britain
DBV Technologies S.A. DBVT	-1.17	$ 22.96	-3.41 %	$ 2.23 B	France
Berkeley Lights BLI	-1.29	-	-7.31 %	$ 87 M	USA
Amneal Pharmaceuticals AMRX	1.01	$ 14.11	1.15 %	$ 4.36 B	USA
AIkido Pharma AIKI	-1.85	-	1.93 %	$ 17.4 M	USA
Bellerophon Therapeutics BLPH	-2.34	-	-74.18 %	$ 955 K	USA
CureVac N.V. CVAC	-2.22	-	-	$ 867 M	Germany
Acer Therapeutics ACER	-1.56	-	2.71 %	$ 14 M	USA
Alpine Immune Sciences ALPN	-1.72	-	-	$ 2.17 B	USA